
NeoGenomics Laboratories specializes in comprehensive cancer genetics testing and information services, offering advanced diagnostics to pharmaceutical clients for clinical trials. Headquartered in Fort Myers, FL, the company operates multiple CAP accredited and CLIA certified laboratories across the United States and Europe, focusing on cytogenetics, flow cytometry, FISH, molecular genetics, immunohistochemistry, and next-gen sequencing (NGS). NeoGenomics is committed to connecting patients with life-altering therapies while adhering to data protection laws and investing in secure technologies.
NeoGenomics is seeking a Senior Director of Research and Development to lead the development of next-generation sequencing clinical diagnostic assays for hematological cancers. This role involves ensuring product development, data analysis, team leadership, and regulatory submission. The company is a world leader in cancer reference laboratories and invests in employee development.
NeoGenomics Laboratories specializes in comprehensive cancer genetics testing and information services, offering advanced diagnostics to pharmaceutical clients for clinical trials. Headquartered in Fort Myers, FL, the company operates multiple CAP accredited and CLIA certified laboratories across the United States and Europe, focusing on cytogenetics, flow cytometry, FISH, molecular genetics, immunohistochemistry, and next-gen sequencing (NGS). NeoGenomics is committed to connecting patients with life-altering therapies while adhering to data protection laws and investing in secure technologies.